News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
559,297 Results
Type
Article (34784)
Company Profile (168)
Press Release (524340)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (155754)
Career Advice (893)
Deals (25402)
Drug Delivery (83)
Drug Development (59941)
Employer Resources (89)
FDA (14390)
Job Trends (12018)
News (261075)
Policy (24345)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2332)
Accelerated approval (19)
Adcomms (10)
Allergies (128)
Alliances (43781)
ALS (114)
Alzheimer's disease (1254)
Antibody-drug conjugate (ADC) (246)
Approvals (14735)
Artificial intelligence (496)
Autoimmune disease (122)
Automation (33)
Bankruptcy (212)
Best Places to Work (9787)
BIOSECURE Act (10)
Biosimilars (92)
Biotechnology (122)
Bladder cancer (132)
Brain cancer (48)
Breast cancer (497)
Cancer (3843)
Cardiovascular disease (305)
Career advice (797)
Career pathing (20)
CAR-T (245)
CDC (30)
Celiac Disease (2)
Cell therapy (631)
Cervical cancer (35)
Clinical research (52016)
Collaboration (1516)
Compensation (438)
Complete response letters (23)
COVID-19 (2109)
CRISPR (89)
C-suite (699)
Cystic fibrosis (101)
Data (5100)
Decentralized trials (2)
Denatured (37)
Depression (102)
Diabetes (391)
Diagnostics (6126)
Digital health (41)
Diversity (11)
Diversity, equity & inclusion (19)
Drug discovery (206)
Drug pricing (102)
Drug shortages (24)
Duchenne muscular dystrophy (170)
Earnings (57600)
Editorial (35)
Employer branding (12)
Employer resources (81)
Events (80737)
Executive appointments (807)
FDA (17110)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (1172)
Gene editing (184)
Generative AI (43)
Gene therapy (468)
GLP-1 (701)
Government (3619)
Grass and pollen (6)
Guidances (322)
Healthcare (15686)
HIV (49)
Huntington's disease (25)
IgA nephropathy (63)
Immunology and inflammation (121)
Immuno-oncology (34)
Indications (84)
Infectious disease (2319)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (97)
Intellectual property (192)
Interviews (115)
IPO (11043)
IRA (29)
Job creations (2592)
Job search strategy (686)
JPM (31)
Kidney cancer (12)
Labor market (49)
Layoffs (284)
Leadership (13)
Legal (4987)
Liver cancer (77)
Longevity (11)
Lung cancer (549)
Lymphoma (303)
Machine learning (38)
Management (35)
Manufacturing (614)
MASH (121)
Medical device (14461)
Medtech (14513)
Mergers & acquisitions (15145)
Metabolic disorders (915)
Multiple sclerosis (123)
NASH (12)
Neurodegenerative disease (225)
Neuropsychiatric disorders (52)
Neuroscience (2155)
NextGen: Class of 2026 (5444)
Non-profit (3500)
Now hiring (40)
Obesity (375)
Opinion (174)
Ovarian cancer (145)
Pain (174)
Pancreatic cancer (170)
Parkinson's disease (209)
Partnered (27)
Patents (394)
Patient recruitment (412)
Peanut (53)
People (49106)
Pharmaceutical (30)
Pharmacy benefit managers (17)
Phase 1 (16122)
Phase 2 (22715)
Phase 3 (17510)
Pipeline (4104)
Policy (160)
Postmarket research (1810)
Preclinical (6239)
Press Release (67)
Prostate cancer (199)
Psychedelics (27)
Radiopharmaceuticals (240)
Rare diseases (574)
Real estate (4695)
Recruiting (37)
Regulatory (19252)
Reports (23)
Research institute (2161)
Resumes & cover letters (138)
Rett syndrome (26)
RNA editing (11)
RSV (59)
Schizophrenia (124)
Series A (194)
Series B (143)
Service/supplier (7)
Sickle cell disease (61)
Special edition (7)
Spinal muscular atrophy (121)
Sponsored (30)
Startups (3248)
State (2)
Stomach cancer (12)
Supply chain (78)
Tariffs (32)
The Weekly (37)
Vaccines (774)
Venture capital (54)
Weight loss (239)
Women's health (70)
Worklife (6)
Date
Today (63)
Last 7 days (434)
Last 30 days (1516)
Last 365 days (22728)
2026 (2143)
2025 (23146)
2024 (27799)
2023 (31987)
2022 (42421)
2021 (45899)
2020 (44737)
2019 (39311)
2018 (29957)
2017 (26892)
2016 (25855)
2015 (30142)
2014 (22891)
2013 (19279)
2012 (20849)
2011 (21337)
2010 (19678)
Location
Africa (549)
Alabama (76)
Alaska (6)
Arizona (241)
Arkansas (13)
Asia (35164)
Australia (5934)
California (8109)
Canada (2643)
China (983)
Colorado (376)
Connecticut (402)
Delaware (288)
Europe (74496)
Florida (1341)
Georgia (301)
Hawaii (3)
Idaho (52)
Illinois (716)
India (45)
Indiana (442)
Iowa (17)
Japan (406)
Kansas (121)
Kentucky (28)
Louisiana (22)
Maine (36)
Maryland (1140)
Massachusetts (5561)
Michigan (322)
Minnesota (519)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (84)
New Hampshire (83)
New Jersey (2438)
New Mexico (22)
New York (2199)
North Carolina (1128)
North Dakota (10)
Northern California (3778)
Ohio (288)
Oklahoma (18)
Oregon (37)
Pennsylvania (1689)
Puerto Rico (22)
Rhode Island (43)
South America (800)
South Carolina (66)
South Dakota (1)
Southern California (3247)
Tennessee (144)
Texas (1341)
United States (30172)
Utah (288)
Vermont (1)
Virginia (180)
Washington D.C. (59)
Washington State (711)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
559,297 Results for "creative medical technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
December 3, 2025
·
3 min read
Press Releases
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 18, 2025
·
4 min read
Press Releases
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
August 14, 2025
·
3 min read
BioMidwest
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
Creative Medical Technology Holdings, Inc. announced that it has successfully generated human induced pluripotent stem cells -derived Islet Cells that produce human insulin.
June 24, 2024
·
3 min read
Press Releases
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
February 5, 2025
·
3 min read
Press Releases
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
February 12, 2025
·
3 min read
Press Releases
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
September 29, 2025
·
3 min read
Press Releases
Belmont Medical Technologies Appoints Brian Larkin as Chief Executive Officer
February 4, 2026
·
4 min read
Policy
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Creative Medical Technology Holdings, Inc. is pleased to announce the successful receipt of Orphan Drug Designation from the U.S. Food and Drug Administration for CELZ-101, ImmCelzTM.
March 6, 2024
·
4 min read
Press Releases
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
March 20, 2025
·
3 min read
1 of 55,930
Next
